JunHe advised Biocytogen on the deal. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced an antibody evaluation and option agreement with Gilead Sciences, Inc. The agreement provides Gilead access...
You must be a Standard 1 Year member to access this content.
JunHe advised Elpiscience on the deal. Elpiscience Biopharma, Ltd. and Astellas Pharma Inc. finalized a research collaboration and license agreement for the novel bispecific macrophage engager (BiME®)...
You must be a Standard 1 Year member to access this content.
JunHe advised Antengene on the deal. Antengene Corporation Limited and Hansoh Pharmaceutical Group Company Limited jointly announced an agreement to collaborate on the commercialization of XPOVIO® and...
You must be a Standard 1 Year member to access this content.
JunHe advised GE Healthcare on the deal. GE Healthcare (China) Co., Ltd. and China National Medical Device Co., Ltd. signed agreements to establish a medical equipment joint...
You must be a Standard 1 Year member to access this content.
JunHe assisted Livzon Pharmaceutical Group on the deal. Livzon Pharmaceutical Group Inc. signed an exclusive license agreement with South Korea-based Onconic Therapeutics Inc. to develop, license and...
You must be a Standard 1 Year member to access this content.
JunHe advised Eucure Biopharma on the deal. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. and Shenzhen Chipscreen Biosciences Ltd. and Chengdu Chipscreen NewWay Biosciences Co., Ltd. had reached an exclusive...
You must be a Standard 1 Year member to access this content.
JunHe assisted Newsoara BioPharma on the deal. Jumpcan Pharmaceutical Group Co., Ltd. had entered into an exclusive agreement with Newsoara BioPharma Co., Ltd. to collaborate on two...
You must be a Standard 1 Year member to access this content.
